User profiles for Sarki A. Abdulkadir

Abdulkadir

İzmir Bakırçay Üniversitesi
Verified email at bakircay.edu.tr
Cited by 21520

[PDF][PDF] SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress

…, O Ozden, SH Park, KK Singh, SA Abdulkadir… - Cancer cell, 2010 - cell.com
The sirtuin gene family (SIRT) is hypothesized to regulate the aging process and play a role
in cellular repair. This work demonstrates that SIRT3 −/− mouse embryonic fibroblasts (MEFs…

Impaired prostate tumorigenesis in Egr1-deficient mice

SA Abdulkadir, Z Qu, E Garabedian, SK Song… - Nature medicine, 2001 - nature.com
The transcription factor, early growth response protein 1 (EGR1), is overexpressed in a majority
of human prostate cancers and is implicated in the regulation of several genes important …

Conditional loss of Nkx3. 1 in adult mice induces prostatic intraepithelial neoplasia

SA Abdulkadir, JA Magee, TJ Peters… - … and cellular biology, 2002 - Am Soc Microbiol
The homeodomain-containing transcription factor NKX3. 1 is a putative prostate tumor
suppressor that is expressed in a largely prostate-specific and androgen-regulated manner. Loss …

[PDF][PDF] Small-molecule MYC inhibitors suppress tumor growth and enhance immunotherapy

…, D Chakravarti, RK Mishra, GE Schiltz, SA Abdulkadir - Cancer cell, 2019 - cell.com
Small molecules that directly target MYC and are also well tolerated in vivo will provide
invaluable chemical probes and potential anti-cancer therapeutic agents. We developed a series …

Emerging therapeutic targets in bladder cancer

…, JJ Meeks, TM Kuzel, M Scaranti, SA Abdulkadir… - Cancer Treatment …, 2015 - Elsevier
Abstract Treatment of muscle invasive urothelial bladder carcinoma (BCa) remains a major
challenge. Comprehensive genomic profiling of tumors and identification of driver mutations …

Turning up the heat on MYC: progress in small-molecule inhibitors

MI Truica, MC Burns, H Han, SA Abdulkadir - Cancer research, 2021 - AACR
MYC is a highly validated oncogenic transcription factor and cancer target. However, the
disordered nature of this protein has made it a challenging target, with no clinical stage, direct …

[HTML][HTML] EGR1 target genes in prostate carcinoma cells identified by microarray analysis

J Svaren, T Ehrig, SA Abdulkadir… - Journal of Biological …, 2000 - ASBMB
The EGR1 transactivator is overexpressed in prostate cancer, and its expression pattern
suggests that EGR1 could potentially regulate a number of steps involved in initiation and …

Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma

…, OE Franco, SW Hayward, ML Wills, SA Abdulkadir - Oncogene, 2010 - nature.com
The oncogenic PIM1 kinase has been implicated as a cofactor for c-MYC in prostate
carcinogenesis. In this study, we show that in human prostate tumors, coexpression of c-MYC and …

Tissue factor expression and angiogenesisin human prostate carcinoma

SA Abdulkadir, GF Carvalhal, Z Kaleem, W Kisiel… - Human pathology, 2000 - Elsevier
In tumors, the switch to the angiogenic phenotype is thought to be controlled by a balance of
positive and negative angiogenic factors. Tissue factor (TF) produced by tumor cells has …

[HTML][HTML] Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines

M Zayzafoon, SA Abdulkadir, JM McDonald - Journal of Biological …, 2004 - ASBMB
Prostate cancer bone metastases are characterized by their ability to induce osteoblastic
lesions and local bone formation. It has been suggested that bone metastatic prostate cancer …